These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34160296)

  • 21. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.
    Peljto AL; Zhang Y; Fingerlin TE; Ma SF; Garcia JG; Richards TJ; Silveira LJ; Lindell KO; Steele MP; Loyd JE; Gibson KF; Seibold MA; Brown KK; Talbert JL; Markin C; Kossen K; Seiwert SD; Murphy E; Noth I; Schwarz MI; Kaminski N; Schwartz DA
    JAMA; 2013 Jun; 309(21):2232-9. PubMed ID: 23695349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis.
    van der Vis JJ; Prasse A; Renzoni EA; Stock CJW; Caliskan C; Maher TM; Bonella F; Borie R; Crestani B; Petrek M; Wuyts WA; Wind AE; Molyneaux PL; Grutters JC; van Moorsel CHM
    Respirology; 2023 May; 28(5):455-464. PubMed ID: 36571111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The MUC5B-associated variant rs35705950 resides within an enhancer subject to lineage- and disease-dependent epigenetic remodeling.
    Gally F; Sasse SK; Kurche JS; Gruca MA; Cardwell JH; Okamoto T; Chu HW; Hou X; Poirion OB; Buchanan J; Preissl S; Ren B; Colgan SP; Dowell RD; Yang IV; Schwartz DA; Gerber AN
    JCI Insight; 2021 Jan; 6(2):. PubMed ID: 33320836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression.
    Juge PA; Solomon JJ; van Moorsel CHM; Garofoli R; Lee JS; Louis-Sydney F; Rojas-Serrano J; González-Pérez MI; Mejia M; Buendia-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou KM; Sidiropoulos P; Trachalaki A; van der Vis JJ; Jamnitski A; Grutters JC; Kannengiesser C; Borie R; Kawano-Dourado L; Wemeau-Stervinou L; Flipo RM; Nunes H; Uzunhan Y; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Richez C; Schaeverbeke T; Doyle T; Wolters PJ; Debray MP; Boileau C; Porcher R; Schwartz DA; Crestani B; Dieudé P
    Semin Arthritis Rheum; 2021 Oct; 51(5):996-1004. PubMed ID: 34411838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome.
    Goos T; Verleden SE; De Sadeleer LJ; Van Herck A; Sacreas A; Vanstapel A; Kaes J; Geudens V; Aelbrecht C; Ruttens D; Lambrechts D; Vermeer S; Ceulemans LJ; Van Raemdonck DE; Godinas L; Yserbyt J; Vanaudenaerde BM; Verleden GM; Vos R; Wuyts WA
    Transpl Int; 2022; 35():10159. PubMed ID: 35651878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.
    Ley B; Newton CA; Arnould I; Elicker BM; Henry TS; Vittinghoff E; Golden JA; Jones KD; Batra K; Torrealba J; Garcia CK; Wolters PJ
    Lancet Respir Med; 2017 Aug; 5(8):639-647. PubMed ID: 28648751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of glutamine transporter ASCT2 mitigates bleomycin-induced pulmonary fibrosis in mice.
    Lian N; Jin H; Zhu W; Zhang C; Qi Y; Jiang M; Mao J; Lu X; Zhao F; Xi B; Qi X; Li Y
    Acta Histochem; 2022 Dec; 124(8):151961. PubMed ID: 36265204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between MUC5B promoter, TERT polymorphisms and telomere lengths with radiographic extent and survival in a Chinese IPF cohort.
    Wang H; Zhuang Y; Peng H; Cao M; Li Y; Xu Q; Xin X; Zhou K; Liang G; Cai H; Dai J
    Sci Rep; 2019 Oct; 9(1):15307. PubMed ID: 31653936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering
    Zhang Q; Wang Y; Qu D; Yu J; Yang J
    Biomed Res Int; 2019; 2019():9712464. PubMed ID: 31309122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity.
    Fadista J; Kraven LM; Karjalainen J; Andrews SJ; Geller F; ; Baillie JK; Wain LV; Jenkins RG; Feenstra B
    EBioMedicine; 2021 Mar; 65():103277. PubMed ID: 33714028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muc5b Enhances Murine Honeycomb-like Cyst Formation.
    Kurche JS; Dobrinskikh E; Hennessy CE; Huber J; Estrella A; Hancock LA; Schwarz MI; Okamoto T; Cool CD; Yang IV; Evans CM; Schwartz DA
    Am J Respir Cell Mol Biol; 2019 Oct; 61(4):544-546. PubMed ID: 31573335
    [No Abstract]   [Full Text] [Related]  

  • 32. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis.
    Horimasu Y; Ohshimo S; Bonella F; Tanaka S; Ishikawa N; Hattori N; Kohno N; Guzman J; Costabel U
    Respirology; 2015 Apr; 20(3):439-44. PubMed ID: 25581455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung Abnormalities.
    Moll M; Peljto AL; Kim JS; Xu H; Debban CL; Chen X; Menon A; Putman RK; Ghosh AJ; Saferali A; Nishino M; Hatabu H; Hobbs BD; Hecker J; McDermott G; Sparks JA; Wain LV; Allen RJ; Tobin MD; Raby BA; Chun S; Silverman EK; Zamora AC; Ortega VE; Garcia CK; Barr RG; Bleecker ER; Meyers DA; Kaner RJ; Rich SS; Manichaikul A; Rotter JI; Dupuis J; O'Connor GT; Fingerlin TE; Hunninghake GM; Schwartz DA; Cho MH
    Am J Respir Crit Care Med; 2023 Oct; 208(7):791-801. PubMed ID: 37523715
    [No Abstract]   [Full Text] [Related]  

  • 34. Colocalization of Gene Expression and DNA Methylation with Genetic Risk Variants Supports Functional Roles of
    Borie R; Cardwell J; Konigsberg IR; Moore CM; Zhang W; Sasse SK; Gally F; Dobrinskikh E; Walts A; Powers J; Brancato J; Rojas M; Wolters PJ; Brown KK; Blackwell TS; Nakanishi T; Richards JB; Gerber AN; Fingerlin TE; Sachs N; Pulit SL; Zappala Z; Schwartz DA; Yang IV
    Am J Respir Crit Care Med; 2022 Nov; 206(10):1259-1270. PubMed ID: 35816432
    [No Abstract]   [Full Text] [Related]  

  • 35. A meta-analysis examining the association between the MUC5B rs35705950 T/G polymorphism and susceptibility to idiopathic pulmonary fibrosis.
    Lee MG; Lee YH
    Inflamm Res; 2015 Jun; 64(6):463-70. PubMed ID: 25926289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.
    Johnson C; Rosen P; Lloyd T; Horton M; Christopher-Stine L; Oddis CV; Mammen AL; Danoff SK
    Respir Med; 2017 Sep; 130():52-54. PubMed ID: 29206633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease.
    Peng R; Sridhar S; Tyagi G; Phillips JE; Garrido R; Harris P; Burns L; Renteria L; Woods J; Chen L; Allard J; Ravindran P; Bitter H; Liang Z; Hogaboam CM; Kitson C; Budd DC; Fine JS; Bauer CM; Stevenson CS
    PLoS One; 2013; 8(4):e59348. PubMed ID: 23565148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MUC5B Promoter Variant rs35705950 Affects MUC5B Expression in the Distal Airways in Idiopathic Pulmonary Fibrosis.
    Nakano Y; Yang IV; Walts AD; Watson AM; Helling BA; Fletcher AA; Lara AR; Schwarz MI; Evans CM; Schwartz DA
    Am J Respir Crit Care Med; 2016 Feb; 193(4):464-6. PubMed ID: 26871673
    [No Abstract]   [Full Text] [Related]  

  • 39. Allies or enemies? The effect of regulatory T cells and related T lymphocytes on the profibrotic environment in bleomycin-injured lung mouse models.
    Seyran M; Melanie S; Philip S; Amiq G; Fabian B
    Clin Exp Med; 2023 Aug; 23(4):1075-1088. PubMed ID: 36403186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
    Juge PA; Lee JS; Ebstein E; Furukawa H; Dobrinskikh E; Gazal S; Kannengiesser C; Ottaviani S; Oka S; Tohma S; Tsuchiya N; Rojas-Serrano J; González-Pérez MI; Mejía M; Buendía-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou K; van Moorsel CHM; van der Vis J; de Man YA; Grutters JC; Wang Y; Borie R; Wemeau-Stervinou L; Wallaert B; Flipo RM; Nunes H; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Marchand-Adam S; Frazier A; Richette P; Allanore Y; Sibilia J; Dromer C; Richez C; Schaeverbeke T; Lioté H; Thabut G; Nathan N; Amselem S; Soubrier M; Cottin V; Clément A; Deane K; Walts AD; Fingerlin T; Fischer A; Ryu JH; Matteson EL; Niewold TB; Assayag D; Gross A; Wolters P; Schwarz MI; Holers M; Solomon JJ; Doyle T; Rosas IO; Blauwendraat C; Nalls MA; Debray MP; Boileau C; Crestani B; Schwartz DA; Dieudé P
    N Engl J Med; 2018 Dec; 379(23):2209-2219. PubMed ID: 30345907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.